The total return over the past 12 months is -2.94% vs. +16.94% for the S&P 500. So far it's up -9.31% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (2.94%) | (67.13%) | (47.19%) | N/A | N/A | N/A |
| Total Return CAGR | (2.94%) | (67.13%) | (47.19%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
OnKure Therapeutics, Inc. (OKUR)
| Year | Start price | End price | OKUR Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.90 | $2.63 | (9.31%) | +14.51% | (23.82%) |
| 2025 | $8.60 | $2.90 | (66.28%) | +17.72% | (84.00%) |
| 2024 | $16.00 | $8.60 | (46.25%) | +24.89% | (71.14%) |
| 2023 | $23.30 | $16.00 | (31.33%) | +26.19% | (57.52%) |
| 2022 | $85.50 | $23.30 | (72.75%) | (18.17%) | (54.58%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
